First Trust Nasdaq Pharmaceuticals ETF
FTXH
11 hedge funds and large institutions have $5.04M invested in First Trust Nasdaq Pharmaceuticals ETF in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 0 closing their positions.
284% more capital invested
Capital invested by funds: $1.31M → $5.04M (+$3.73M)
35.71% more ownership
Funds ownership: 18.42% → 54.13% (+36%)
22% more funds holding
Funds holding: 9 → 11 (+2)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SMFS
Squar Milner Financial Services
Irvine,
California
|
+$123K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$68.7K |
| 3 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$14K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$6.53K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$147K |
| 2 |
LPL Financial
San Diego,
California
|
-$27.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$7.68K |
FTXH Hedge Fund Activity: Q4 2019 in Review
11 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) for Q4 2019, worth a combined $5.04M — up 284% from $1.31M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new FTXH positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Squar Milner Financial Services, opening a new position worth an estimated $123K. The largest seller was Jane Street, cutting an estimated $147K.
- 11 institutional investors held First Trust Nasdaq Pharmaceuticals ETF (FTXH) as of Q4 2019, up from 9 in Q3 2019.
- Funds reported $5.04M of First Trust Nasdaq Pharmaceuticals ETF stock for Q4 2019, up 284% quarter-over-quarter.
- 2 funds opened new First Trust Nasdaq Pharmaceuticals ETF positions in Q4 2019 and 0 closed out, a net change of +2 holders.
- The largest First Trust Nasdaq Pharmaceuticals ETF buyer in Q4 2019 was Squar Milner Financial Services, an estimated $123K added.
- The largest First Trust Nasdaq Pharmaceuticals ETF seller in Q4 2019 was Jane Street, an estimated $147K sold.
Based on aggregated 13F filings for Q4 2019.